PB1820: CD47‐BLOCKER TTI‐622 COMBINED WITH AZACITIDINE IN PATIENTS WITH TP53‐MUTATED ACUTE MYELOID LEUKEMIA (AML) AND WITH AZACITIDINE + VENETOCLAX IN ELDERLY OR UNFIT PATIENTS WITH TP53‐WILDTYPE AML

Saved in:
Bibliographic Details
Published inHemaSphere Vol. 6; no. Suppl; pp. 1700 - 1701
Main Authors Daver, N., Maris, M., Ramchandren, R., Bixby, D., Doucette, K., Mawad, R., Egan, D., Stevens, D., Zonder, J., Molloy, N., Scheuber, A., Bruns, I., Mantzaris, I., Konopleva, M., Goldberg, A. D.
Format Journal Article
LanguageEnglish
Published Philadelphia, PA Lippincott Williams & Wilkins 23.06.2022
Wiley
Subjects
Publication Only
Online AccessGet full text

Cover

More Information
ISSN:2572-9241
2572-9241
DOI:10.1097/01.HS9.0000850132.55221.5c